Gert G reported that CAV1 and CAV2 were highly expressed in inflammatory breast cancer (IBC), and the CAV1 and CAV2 promoter sites were hypomethylated in SUM149 cells (Van den Eynden et al., 2006). This evidence concerns the gene CAV1 and inflammatory breast carcinoma.